Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

Long-Term Follow-Up of Selected Patients Enrolled in Phase 3 Clinical Trial 127-014 Using PB127 Ultrasound Imaging Agent

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00584714

Enrollment

300

Registered

2008-01-02

Start date

2007-10-31

Completion date

2008-07-31

Last updated

2008-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

ultrasound, perfusion, SPECT, coronary artery disease, chest pain, low probability, angiography, clinical outcomes

Brief summary

The purpose of this study is to collect longer term follow-up information concerning health and survival on selected patients who received PB127 for injectable suspension in the pivotal trial (127-014).

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Patients enrolled in Protocol 127-014 who 1. Were enrolled in Stratum 1 2. Did not undergo angiography during study evaluation 3. Did not have a clinical oucome during the initial 6 month follow-up period as described in Protocol 127-014.

Design outcomes

Primary

Measure	Time frame
To collect longer-term follow-up clinical information on selected patients enrolled in Protocol 127-014	1 year

Countries

United States

Outcome results